Management of Helicobacter pylori Infection | 合法醫療器材資訊網

由LMyran著作·2018·被引用3次—Nonbismuthquadrupletherapy(i.e.,concomitant)for10to14days(theTorontoConsensusstronglyrecommends14days)isanotherfirst-line ...

US Pharm. 2018;43(4):27-32.

ABSTRACT: Helicobacter pylori infection is prevalent in about one-half of the world’s population. Infection with H pylori is associated with the development of peptic ulcer disease, gastric cancer, and mucosa-associated lymphoid tissue lymphoma. Significant scientific advances have been made in the management of H pylori infection in adults; these advances are addressed in updated recommendations by the American College of Gastroenterology and the Toronto Consensus. The increasing prevalence of H pylori that is resistant to traditional clarithromycin-based therapies is a global problem requiring a review of the evidence to incorporate additional regimens.

Helicobacter pylori is a gram-negative bacterium that colonizes the human stomach. It is typically acquired during childhood and transmitted from human to human.1,2 Risk factors for H...